Skip to content

Company · founded 1997

Xencor (United States)

Monrovia, United States · xencor.com

Manage this page

Citations, last 5 years: 448
Works, last 5 years: 56
h-index: 129
Scientists listed: 12
Grants since 2016: 3

Grants received

2018–2022 · research · R44

IND-enabling Epicardial Biopharmaceutical in the Diabetic Heart

Pilar Ruiz-Lozano · Xencor (United States) · funded by National Institutes of Health

$2MTissue Engineering and Regenerative Medicine

2018–2019 · research · R44

IND-enabling Epicardial Biopharmaceutical in the Diabetic Heart

Pilar Ruiz-Lozano · Xencor (United States) · funded by National Institutes of Health

$444.8kTissue Engineering and Regenerative Medicine

2018–2023 · research · R44

IND-enabling Epicardial Biopharmaceutical in the Diabetic Heart

Pilar Ruiz-Lozano · Xencor (United States) · funded by National Institutes of Health

$1.8MTissue Engineering and Regenerative Medicine